Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and business highlights for the three months ended July 31, 2022.

During the period, numbers reflected:

As for business updates, Awakn’s Phase III trial recently received approx. …

Full story available on Benzinga.com